View in EDS HTML Full Text PDF Full Text

Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder

Saved in:
Bibliographic Details
Title: Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
Language: English
Authors: Amber Davis (ORCID 0000-0002-5448-9775), Kathryn Van Eck, Nikeea Copeland-Linder, Karen Phuong, Harolyn M.E. Belcher
Source: Journal of Autism and Developmental Disorders. 2024 54(6):2347-2354.
Availability: Springer. Available from: Springer Nature. One New York Plaza, Suite 4600, New York, NY 10004. Tel: 800-777-4643; Tel: 212-460-1500; Fax: 212-460-1700; e-mail: customerservice@springernature.com; Web site: https://link.springer.com/
Peer Reviewed: Y
Page Count: 8
Publication Date: 2024
Sponsoring Agency: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (DHHS/NIH)
Contract Number: T32HD094687
Document Type: Journal Articles
Reports - Research
Descriptors: Hospitals, Autism Spectrum Disorders, Risk, COVID-19, Pandemics, Comorbidity, Patients, Death, Health Insurance, Mortality Rate
DOI: 10.1007/s10803-023-05971-2
ISSN: 0162-3257
1573-3432
Abstract: Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1426465
Database: ERIC
Full text is not displayed to guests.
Description
Abstract:Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients.
ISSN:0162-3257
1573-3432
DOI:10.1007/s10803-023-05971-2